Want to see HK:3886 full AI Analyst Report?
Town Health International Medical Group Ltd. (3886) Ratios
Town Health International Medical Group Ltd. Ratios
HK:3886's free cash flow for Q2 2026 was $109.43M. For the 2026 fiscal year, HK:3886's free cash flow was decreased by $-5.75M and operating cash flow was $136.24M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.64 | 3.19 | 3.25 | 3.90 | 5.64 |
| Quick Ratio | 3.54 | 3.10 | 3.15 | 3.77 | 5.55 |
| Cash Ratio | 2.36 | 2.01 | 1.73 | 1.97 | 2.16 |
| Solvency Ratio | 0.26 | -0.18 | -0.06 | 0.16 | 0.29 |
| Operating Cash Flow Ratio | 0.29 | 0.41 | 0.41 | 0.06 | 0.41 |
| Short-Term Operating Cash Flow Coverage | 1.95 | 1.46 | 1.78 | 0.68 | 11.10 |
| Net Current Asset Value | $ 1.28B | $ 1.15B | $ 1.06B | $ 1.03B | $ 1.87B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.09 | 0.10 | 0.10 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.12 | 0.14 | 0.14 | 0.03 |
| Debt-to-Capital Ratio | 0.05 | 0.11 | 0.12 | 0.12 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.02 | 0.05 | 0.07 | 0.00 |
| Financial Leverage Ratio | 1.32 | 1.39 | 1.39 | 1.36 | 1.23 |
| Debt Service Coverage Ratio | 1.95 | 0.66 | 0.09 | 3.44 | 8.72 |
| Interest Coverage Ratio | 6.84 | 4.42 | 4.38 | 1.21 | -1.83 |
| Debt to Market Cap | 0.04 | 0.14 | 0.14 | 0.12 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.06 | 0.07 | 0.07 | 0.02 |
| Net Debt to EBITDA | -4.95 | -5.19 | -10.75 | -2.09 | -3.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.47% | 26.58% | 27.38% | 26.99% | 31.76% |
| EBIT Margin | 4.41% | 4.94% | -5.03% | 7.16% | 6.58% |
| EBITDA Margin | 11.77% | 8.76% | 2.92% | 15.47% | 14.81% |
| Operating Profit Margin | 4.41% | 4.94% | 5.59% | 1.00% | -0.48% |
| Pretax Profit Margin | 5.88% | -6.25% | -6.59% | 5.37% | 8.53% |
| Net Profit Margin | 0.81% | -11.11% | -10.59% | 1.00% | 1.48% |
| Continuous Operations Profit Margin | 3.63% | -8.63% | -8.68% | 3.22% | 5.06% |
| Net Income Per EBT | 13.69% | 177.85% | 160.69% | 18.53% | 17.40% |
| EBT Per EBIT | 133.26% | -126.38% | -117.97% | 538.88% | -1770.09% |
| Return on Assets (ROA) | 0.36% | -4.94% | -4.32% | 0.32% | 0.47% |
| Return on Equity (ROE) | 0.48% | -6.84% | -5.99% | 0.44% | 0.57% |
| Return on Capital Employed (ROCE) | 2.28% | 2.57% | 2.62% | 0.36% | -0.17% |
| Return on Invested Capital (ROIC) | 1.36% | 2.40% | 2.49% | 0.21% | -0.10% |
| Return on Tangible Assets | 0.49% | -6.48% | -5.67% | 0.43% | 0.56% |
| Earnings Yield | 0.85% | -12.27% | -8.96% | 0.55% | 0.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.64 | 4.70 | 4.27 | 3.02 | 3.40 |
| Payables Turnover | 9.29 | 7.81 | 8.46 | 7.30 | 7.06 |
| Inventory Turnover | 29.98 | 26.32 | 22.60 | 17.32 | 26.18 |
| Fixed Asset Turnover | 4.55 | 1.90 | 3.97 | 2.27 | 3.26 |
| Asset Turnover | 0.45 | 0.44 | 0.41 | 0.32 | 0.31 |
| Working Capital Turnover Ratio | 1.36 | 1.39 | 1.32 | 0.91 | 0.76 |
| Cash Conversion Cycle | 73.21 | 44.86 | 58.46 | 91.82 | 69.51 |
| Days of Sales Outstanding | 100.31 | 77.73 | 85.44 | 120.71 | 107.29 |
| Days of Inventory Outstanding | 12.18 | 13.87 | 16.15 | 21.08 | 13.94 |
| Days of Payables Outstanding | 39.28 | 46.74 | 43.12 | 49.97 | 51.72 |
| Operating Cycle | 112.48 | 91.60 | 101.59 | 141.79 | 121.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.04 | 0.04 | 0.00 | 0.02 |
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.03 | -0.00 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 5.66 | 5.23 | 9.57 | 0.65 | 8.57 |
| Capital Expenditure Coverage Ratio | 8.23 | 6.32 | 13.95 | 0.85 | 8.57 |
| Operating Cash Flow Coverage Ratio | 1.00 | 0.68 | 0.54 | 0.07 | 1.45 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.13 | 0.14 | 0.02 | 0.12 |
| Free Cash Flow Yield | 7.63% | 12.42% | 10.60% | -0.20% | 4.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 119.05 | -8.15 | -11.16 | 182.44 | 150.43 |
| Price-to-Sales (P/S) Ratio | 0.95 | 0.90 | 1.18 | 1.82 | 2.23 |
| Price-to-Book (P/B) Ratio | 0.56 | 0.56 | 0.67 | 0.80 | 0.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.11 | 8.05 | 9.43 | -510.39 | 21.93 |
| Price-to-Operating Cash Flow Ratio | 11.51 | 6.78 | 8.76 | 87.90 | 19.37 |
| Price-to-Earnings Growth (PEG) Ratio | -1.11 | -1.67 | 0.01 | -6.61 | -1.40 |
| Enterprise Value Multiple | 3.11 | 5.14 | 29.77 | 9.65 | 11.46 |
| Enterprise Value | 652.92M | 825.73M | 1.59B | 2.29B | 2.52B |
| EV to EBITDA | 3.11 | 5.14 | 29.77 | 9.65 | 11.46 |
| EV to Sales | 0.37 | 0.45 | 0.87 | 1.49 | 1.70 |
| EV to Free Cash Flow | 5.05 | 4.01 | 6.93 | -419.46 | 16.68 |
| EV to Operating Cash Flow | 4.44 | 3.37 | 6.43 | 72.24 | 14.74 |
| Tangible Book Value Per Share | 0.35 | 0.35 | 0.38 | 0.36 | 0.45 |
| Shareholders’ Equity Per Share | 0.44 | 0.44 | 0.48 | 0.48 | 0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.38 | -0.32 | -0.32 | 0.40 | 0.41 |
| Revenue Per Share | 0.26 | 0.27 | 0.27 | 0.21 | 0.20 |
| Net Income Per Share | 0.00 | -0.03 | -0.03 | 0.00 | 0.00 |
| Tax Burden | 0.14 | 1.78 | 1.61 | 0.19 | 0.17 |
| Interest Burden | 1.33 | -1.26 | 1.31 | 0.75 | 1.30 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.22 | 0.22 | 0.22 | 0.26 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.27 | -1.55 | -1.27 | 0.64 | 2.28 |
Currency in HKD